Advertisement

Picture Excelya CRO Logo Clinical Research 650x80px
Organisation › Details

SynOx Therapeutics Ltd.

SynOx is a clinical stage biopharmaceutical company. It is a spin out from Celleron Therapeutics Ltd, an oncology company focused on the clinical development of new and innovative therapies to treat cancer. SynOx is developing emactuzumab, a best-in-class CSF1R targeted therapeutic antibody designed to target and deplete tumour-associated macrophages in the tumour tissue. SynOx is led by a team of experts that combines biotech and pharma experience with a successful track record of developing and bringing products to market. It is backed by a strong investor syndicate – HealthCap, Medicxi, Forbion and Gimv. *

 

Period Start 2020-11-19 existent (s-off)
  Today Celleron Therapeutics Ltd.
  Predecessor Celleron Therapeutics Ltd.
Products Industry emactuzumab
  Industry 2 drug development
Person Person La Thangue, Nick (SynOx Therapeutics 202011 CEO)
     
  City n. a. Dublin
    Address record changed: 2021-01-18
     
Basic data Employees n. a.
     
    * Document for �About Section�: SynOx Therapeutics Ltd.. (11/19/20). "Press Release: SynOx Therapeutics Raises €37M in Series A Financing. HealthCap and Medicxi Co-lead, Joined by Forbion and Gimv". Dublin.
     
   
Record changed: 2020-11-19

Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px

More documents for SynOx Therapeutics Ltd.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Excelya CRO Quality Agility for Your Research 650x80px




» top